About Exo
Exo is a company based in Redwood City (United States) founded in 2015 by Sandeep Akkaraju, John Kokulis, Janusz Bryzek, and Yusuf Haque. It operates as a AI-as-a-Service, Direct-to-Consumer (D2C), and HealthTech. Exo has raised $463.39 million across 11 funding rounds from investors including Applied Materials, BlackRock and RA Capital. Exo has completed 1 acquisition, including MEDO. Exo offers products and services including Exo Iris, Exo Works, Exo AI, and SweepAI. Exo operates in a competitive market with competitors including Butterfly Network, SonoSite, EchoNous, Zonare Medical Systems and TechsoMed, among others.
- Headquarter Redwood City, United States
- Founders Sandeep Akkaraju, John Kokulis, Janusz Bryzek, Yusuf Haque
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Exo Imaging, Inc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$463.39 M (USD)
in 11 rounds
-
Latest Funding Round
$43.94 M (USD), Series C
May 28, 2025
-
Investors
Applied Materials
& 19 more
-
Employee Count
Employee Count
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Exo
Exo offers a comprehensive portfolio of products and services, including Exo Iris, Exo Works, Exo AI, and SweepAI. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Handheld ultrasound device used for point-of-care imaging.
Software designed for ultrasound scanning and documentation.
AI tool used for automated ultrasound diagnostics.
AI technology used for real-time ultrasound insights.
Unlock access to complete
Unlock access to complete
Funding Insights of Exo
Exo has successfully raised a total of $463.39M across 11 strategic funding rounds. The most recent funding activity was a Series C round of $43.94 million completed in May 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 11
- Last Round Series C — $43.9M
-
First Round
First Round
(12 Apr 2017)
- Investors Count 20
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May, 2025 | Amount | Series C - Exo | Valuation |
investors |
|
| Jan, 2025 | Amount | Debt – Conventional - Exo | Valuation |
investors |
|
| Jul, 2024 | Amount | Debt – Conventional - Exo | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Exo
Exo has secured backing from 20 investors, including institutional and venture fund investors. Prominent investors backing the company include Applied Materials, BlackRock and RA Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investment management services are provided focusing on healthcare innovation.
|
Founded Year | Domain | Location | |
|
Growth stage tech & life sciences focused VC Firm investing in Asia and the US
|
Founded Year | Domain | Location | |
|
Early-stage tech startups are invested in globally by TDK Ventures.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Exo
Exo has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include MEDO. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
AI-augmented 3D ultrasound devices are developed for point-of-care diagnostics.
|
2017 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Exo
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Exo Comparisons
Competitors of Exo
Exo operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Butterfly Network, SonoSite, EchoNous, Zonare Medical Systems and TechsoMed, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Handheld ultrasound devices are developed for whole-body medical imaging.
|
|
| domain | founded_year | HQ Location |
Hand-carried ultrasound systems for medical specialties are developed and distributed.
|
|
| domain | founded_year | HQ Location |
AI-assisted handheld ultrasound devices are provided for medical diagnostics.
|
|
| domain | founded_year | HQ Location |
Portable ultrasound systems are developed and provided for medical use.
|
|
| domain | founded_year | HQ Location |
Ultrasound-based monitoring systems for thermal ablation procedures are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Exo
Frequently Asked Questions about Exo
When was Exo founded?
Exo was founded in 2015 and raised its 1st funding round 2 years after it was founded.
Where is Exo located?
Exo is headquartered in Redwood City, United States. It is registered at Redwood City, California, United States.
Who is the current CEO of Exo?
Sandeep Akkaraju is the current CEO of Exo. They have also founded this company.
Is Exo a funded company?
Exo is a funded company, having raised a total of $463.39M across 11 funding rounds to date. The company's 1st funding round was a Debt – Conventional of $20.67M, raised on Apr 12, 2017.
What does Exo do?
Exo is engaged in creating a point-of-care ultrasound (POCUS) ecosystem that enables caregivers to access medical imaging anywhere. The company offers handheld ultrasound devices like Exo Iris, powered by advanced AI for high-performance imaging. Solutions such as Exo Works streamline scanning, documentation, and billing processes. Additionally, Exo AI and SweepAI provide real-time diagnostic insights for cardiac and lung conditions. Operating in the healthcare sector, Exo targets medical professionals and institutions with innovative tools to improve diagnostic accuracy and patient outcomes.
Who are the top competitors of Exo?
Exo's top competitors include Butterfly Network, TechsoMed and EchoNous.
What products or services does Exo offer?
Exo offers Exo Iris, Exo Works, Exo AI, and SweepAI.
How many acquisitions has Exo made?
Exo has made 1 acquisition, including MEDO.
Who are Exo's investors?
Exo has 20 investors. Key investors include Applied Materials, BlackRock, RA Capital, Sony Innovation Fund, and OSF HealthCare.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.